$42.0M
The equity round was led by EQT Life Sciences and Sectoral to support international expansion and clinical trials.
Phagenesis develops neurostimulation technology to treat swallowing disorders.
Manchester-based medical device startup that develops neurostimulation systems to treat swallowing disorders.
Mark Wyatt
Conor Mulrooney
Co-Founder
Shaheen Hamdy
Co-Founder
Reinhard Krickl
CEO
The equity round was led by EQT Life Sciences and Sectoral to support international expansion and clinical trials.